TargetSuppressor of tumorigenicity 14 protein(Homo sapiens (Human))
The Medicines Company (Leipzig)
US Patent
The Medicines Company (Leipzig)
US Patent
Affinity DataKi: 30.5nMAssay Description:Inhibition assay using matriptase enzymeMore data for this Ligand-Target Pair
TargetSuppressor of tumorigenicity 14 protein(Homo sapiens (Human))
The Medicines Company (Leipzig)
US Patent
The Medicines Company (Leipzig)
US Patent
Affinity DataKi: 31nMAssay Description:Inhibition of matriptase (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 1.30E+3nMAssay Description:Inhibition of plasmin (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 2.10E+3nMAssay Description:Inhibition of thrombin (unknown origin)More data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
The Medicines Company (Leipzig)
Curated by ChEMBL
The Medicines Company (Leipzig)
Curated by ChEMBL
Affinity DataKi: 7.40E+3nMAssay Description:Inhibition of uPA (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 1.50E+4nMAssay Description:Inhibition of factor 10a (unknown origin)More data for this Ligand-Target Pair